[ Price : $8.95]
Federal Register notice: FDA makes available a final guidance entitled Population Pharmacokinetics.[ Price : $8.95]
Federal Register notice: FDA makes available a revised draft guidance entitled Assessment of Pressor Effects of Drugs.[ Price : $8.95]
Federal Register notice: FDA classifies Apples photoplethysmograph analysis software for over-the-counter use into medical device ...[ Price : $8.95]
FDA accepts for review a Cytokinetics NDA for omecamtiv mecarbil, an investigational, selective, small molecule cardiac myosin act...[ Price : $8.95]
In a move to gain Senate backing of his FDA commissioner nomination, Robert Califf promises once in office to crack down on drug c...[ Price : $8.95]
Three Congressional representatives introduce bipartisan legislation intended to increase diversity in clinical trials.[ Price : $8.95]
Pfizer and Ionis say they are discontinuing a development program for vupanorsen for potential cardiovascular risk reduction.[ Price : $8.95]
The FDA Office of Clinical Pharmacology issues its 2021 annual report with an outlook for 2022.